Franklin Limited Duration Income Trust Announces Sources of Monthly Dividend Distribution
Mar 12, 2018 20:05 pm UTC| Business
SAN MATEO, Calif., March 12, 2018 -- The Franklin Limited Duration Income Trust (NYSE:FTF) (CUSIP 35472T101) has declared a dividend of $0.1030 per common share payable March 15, 2018, to shareholders of record as of...
Mar 12, 2018 20:05 pm UTC| Business
RANCHO CUCAMONGA, Calif., March 12, 2018 -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the three months and fiscal year ended December 31, 2017. Fourth...
Mar 12, 2018 20:05 pm UTC| Business
CAMBRIDGE, Mass. and CARLSBAD, Calif. , March 12, 2018 -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), and Ionis Pharmaceuticals, Inc., today announced the...
Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2017 Operating Results
Mar 12, 2018 20:05 pm UTC| Business
2017 Revenue of $134.5 million, growth of 43%; 4Q 2017 Revenue of $43.9 million, growth of 61% Provides initial 2018 financial outlook MOORESTOWN, N.J., March 12, 2018 -- Tabula Rasa HealthCare, Inc. (“TRHC”)...
Mar 12, 2018 20:05 pm UTC| Business
Company Remains on Target for Full Year Revenue of $50.0 - $55.0 Million Intensified Business Development Effort Results in New Customer Contract and Strengthened Backlog TUSTIN,...
Mar 12, 2018 20:05 pm UTC| Business
– Company plans to initiate registration-directed trial of tipifarnib in second half of 2018 following recent end of Phase 2 meeting with the FDA – – Single-arm trial to enroll at least 59 recurrent or metastatic HRAS...
Aquinox Pharmaceuticals Announces Year End 2017 Financial Results
Mar 12, 2018 20:05 pm UTC| Business
VANCOUVER, British Columbia, March 12, 2018 -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat...